“We struggle to see the strategic fit,” Leerink Partners analyst Puneet Souda, who has an Outperform rating on Exact Sciences ...
President Donald Trump infamously asserted during the September 2024 presidential debate that he had “concepts of a plan” to ...
The fall COVID-19 vaccine season is starting slowly for Pfizer, with U.S. sales of its Comirnaty shots sinking 25% after federal regulators narrowed recommendations on who should get them. Approval of ...
As is the case every year, new variants of the virus that causes COVID-19 are circulating in Europe. In Germany, the variant XFG is now dominant. It is often referred to in the media as the ...
A dearth of African-language content is delaying the uptake of artificial intelligence on the continent, compounding a lack of access to the technology, according to mobile industry body GSMA. The ...
WASHINGTON (AP) — The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients – revving up their immune systems to help fight tumors. People with advanced lung or skin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback